Displaying drugs 551 - 575 of 819 in total
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Phosphoramidon
Experimental
2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate
Experimental
Trifluorofurnesyl Diphosphate
Experimental
8-Bromo-Adenosine-5'-Monophosphate
Experimental
N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE
Experimental
2'-Deoxy-thymidine-beta-L-rhamnose
Experimental
Aspartyl-Adenosine-5'-Monophosphate
Experimental
Uridine-Diphosphate-N-Acetylgalactosamine
Experimental
Guanosine-5'-Diphosphate-Rhamnose
Experimental
Uridine-Diphosphate-N-Acetylglucosamine
Experimental
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose
Experimental
7-methyl-7,8-dihydroguanosine-5'-diphosphate
Experimental
Adenosine-5'-Pentaphosphate
Experimental
Cytidyl-2'-5'-phospho-guanosine
Experimental
4-Phospho-D-erythronohydroxamic acid
Experimental
Canfosfamide
Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.
Investigational
CTT-1057
CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
Investigational
8-Bromoadenosine-5'-Diphosphate
Experimental
7-methyl-GpppA
Experimental
Displaying drugs 551 - 575 of 819 in total